FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $562,000 | -70.9% | 283,820 | -49.9% | 0.00% | -80.0% |
| Q3 2021 | $1,931,000 | -78.7% | 566,207 | -49.1% | 0.01% | -61.5% |
| Q2 2021 | $9,058,000 | +32.5% | 1,111,510 | +100.0% | 0.01% | -38.1% |
| Q1 2021 | $6,836,000 | -32.1% | 555,778 | +0.8% | 0.02% | -34.4% |
| Q4 2020 | $10,070,000 | +17.5% | 551,476 | +0.4% | 0.03% | +3.2% |
| Q3 2020 | $8,572,000 | – | 549,154 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,466,507 | $6,217,990 | 9.26% |